I am a
Home I AM A Search Login

Papers of the Week

Papers: 21 Jan 2023 - 3 Feb 2023

2023 Jan 30

Sci Rep



Diagnosis and treatment of intractable idiopathic orofacial pain with attention-deficit/hyperactivity disorder.


Kasahara S, Takahashi K, Matsudaira K, Sato N, Fukuda K-ichi, Toyofuku A, Yoshikawa T, Kato Y, Niwa S-I, Uchida K
Sci Rep. 2023 Jan 30; 13(1):1678.
PMID: 36717626.


Attention-deficit/hyperactivity disorder (ADHD) has been reported to be associated with primary chronic pain syndromes, such as fibromyalgia, migraine, and chronic low back pain. Although idiopathic orofacial pain (IOP) is classified as burning mouth syndrome or persistent idiopathic facial or dentoalveolar pain and as a primary chronic pain, the association between IOP and ADHD has not been investigated. This retrospective cohort study investigated the severity of ADHD symptoms measured using the ADHD scale and the effects of treatment using ADHD drugs and the dopamine system stabilizer aripiprazole. The participants were 25 consecutive patients with refractory IOP referred to a psychiatrist and diagnosed with coexisting ADHD according to the Diagnostic and Statistical Manual of Mental Disorders-5. The ADHD scale scores were higher in patients with intractable IOP than those in the general population. Pharmacotherapy used in this study led to clinically significant improvements in pain, anxiety/depression, and pain catastrophizing. Intractable IOP and ADHD were shown to be associated. In the future, screening and pharmacotherapy for ADHD should be considered in the treatment of intractable IOP.